NCT01072591View on ClinicalTrials.gov

Study to Assess MEDI -578 in Patients With Osteoarthritis (OA) of the Knee

PHASE1TerminatedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

OsteoarthritisPain

Interventions

DRUG

MEDI-578

intravenous infusion, once

DRUG

Placebo for MEDI-578

Intravenous infusion, once

Trial Locations (1)

Unknown

Research Site, London Bridge

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

MedImmune LLC

INDUSTRY

lead

AstraZeneca

INDUSTRY